Form 4: Executive's RSU Grant Rescinded by Nature's Sunshine
Insider Transaction Report
Nature's Sunshine Products rescinded a grant of 7,250 restricted stock units to EVP and General Counsel Nathan G. Brower shortly after the initial grant.
Summary
- EVP and General Counsel Nathan G. Brower was granted 7,250 restricted stock units (RSUs) on March 6, 2026.
- These RSUs were scheduled to vest in three equal annual installments through March 6, 2029.
- The company subsequently rescinded and cancelled all 7,250 restricted stock units on March 24, 2026.
- No restricted stock units had vested prior to their cancellation.
- Brower's direct beneficial ownership of common shares remains at 43,634.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as slightly negative due to the unusual rescission of an RSU grant, which could imply internal administrative issues or a change in executive compensation strategy, potentially impacting executive morale or perception of governance.
Negatives
- The rescission of 7,250 restricted stock units for EVP and General Counsel Nathan G. Brower indicates a potential issue with the initial grant or a change in compensation strategy.
- The executive lost out on potential future equity compensation.
Risks
- Potential for negative perception regarding internal compensation processes or executive retention if the rescission was due to internal issues.
- Uncertainty regarding the reason for the rescission could raise questions about corporate governance or executive compensation practices.
Future Outlook
No explicit forward-looking statements or guidance are provided in this filing beyond the original vesting schedule for the now-cancelled RSUs.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine for insider transactions, but the rescission of an RSU grant shortly after issuance is less common and could signal internal adjustments to compensation plans or a specific executive's package, diverging from typical equity award practices.
Comparison to Industry Standards
- This specific event (grant and quick rescission) is not a standard industry practice. Typically, RSU grants are finalized and only forfeited upon departure or failure to meet conditions.
- The immediate cancellation suggests an administrative error or a rapid change in decision, which is unusual compared to standard executive compensation practices at companies like Pfizer or Johnson & Johnson, where RSU grants are typically firm once announced.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Adjustment | Rescission of 7,250 restricted stock units granted to EVP and General Counsel Nathan G. Brower. | 03/24/2026 | Could indicate a review or adjustment of executive compensation policies or an administrative correction related to the grant. |
Stakeholder Impact
- Shareholders: Minor potential concern regarding clarity of executive compensation practices, but no direct financial impact from the cancellation itself.
- Executive (Nathan G. Brower): Loss of potential future equity compensation.
Key Dates
| Date | Description |
|---|---|
| 03/06/2026 | Grant of 7,250 restricted stock units to Nathan G. Brower. |
| 03/24/2026 | Rescission and cancellation of 7,250 restricted stock units. |
| 03/25/2026 | Signature date of the reporting person on the Form 4. |
| 03/06/2029 | Original final vesting date for the rescinded restricted stock units. |
Recommendation
holdThe filing details an administrative correction regarding an executive's RSU grant, which is not a material event impacting the company's fundamentals or operational outlook. While the rescission is unusual, it doesn't provide sufficient information to warrant a change in investment stance. Investors should hold and monitor for further clarity on executive compensation practices if this becomes a recurring theme.
Keywords
Nature's Sunshine Products, NATR, SEC Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Nathan Brower, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.